{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T03:34:14Z","timestamp":1764732854399,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002380","name":"Hanyang University","doi-asserted-by":"publisher","award":["HY-2015"],"award-info":[{"award-number":["HY-2015"]}],"id":[{"id":"10.13039\/501100002380","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.prp.2020.152821","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T02:27:38Z","timestamp":1578623258000},"page":"152821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prognostic value of B-cell linker protein in colorectal cancer"],"prefix":"10.1016","volume":"216","author":[{"given":"Jun Ho","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung Kyu","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Sam","family":"Paik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang Hong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2020.152821_bib0005","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.molimm.2010.12.007","article-title":"Regulation of BCR signaling","volume":"48","author":"Kurosaki","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.prp.2020.152821_bib0010","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.immuni.2008.04.007","article-title":"New insights into the early molecular events underlying B cell activation","volume":"28","author":"Harwood","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.prp.2020.152821_bib0015","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1126\/science.286.5446.1954","article-title":"An essential role for BLNK in human B cell development","volume":"286","author":"Minegishi","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.prp.2020.152821_bib0020","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1182\/blood-2006-02-005397","article-title":"Human SLP-65 isoforms contribute differently to activation and apoptosis of B lymphocytes","volume":"108","author":"Grabbe","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.prp.2020.152821_bib0025","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nature01608","article-title":"Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia","volume":"423","author":"Jumaa","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.prp.2020.152821_bib0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/ni862","article-title":"The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion","volume":"4","author":"Flemming","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.prp.2020.152821_bib0035","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1182\/blood-2008-07-166355","article-title":"BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3","volume":"113","author":"Nakayama","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.prp.2020.152821_bib0040","doi-asserted-by":"crossref","first-page":"23960","DOI":"10.18632\/oncotarget.25251","article-title":"Identification of different mutational profiles in cancers arising in specific colon segments by next generation sequencing","volume":"9","author":"Oliveira","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2020.152821_bib0045","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1074-7613(00)80130-2","article-title":"Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65","volume":"11","author":"Jumaa","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.prp.2020.152821_bib0050","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1073\/pnas.051626198","article-title":"BLNK mediates syk-dependent btk activation","volume":"98","author":"Baba","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.prp.2020.152821_bib0055","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1002\/1521-4141(200107)31:7<2164::AID-IMMU2164>3.0.CO;2-S","article-title":"The absence of SLP65 and Btk blocks B cell development at the preB cell receptor-positive stage","volume":"31","author":"Jumaa","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.prp.2020.152821_bib0060","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1038\/onc.2015.504","article-title":"A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation","volume":"35","author":"Grassilli","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2020.152821_bib0065","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1158\/0008-5472.CAN-18-3880","article-title":"Long noncoding RNA MIR17HG promotes colorectal Cancer progression via miR-17-5p","volume":"79","author":"Xu","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2020.152821_bib0070","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.4049\/jimmunol.176.6.3498","article-title":"Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells","volume":"176","author":"Crawford","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.prp.2020.152821_bib0075","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.0300-9475.2004.01517.x","article-title":"B-Lymphocytes activated by CD40 ligand induce an antigen-specific anti-tumour immune response by direct and indirect activation of CD8(+) T-cells","volume":"60","author":"Ritchie","year":"2004","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.prp.2020.152821_bib0080","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1016\/j.ajpath.2014.07.003","article-title":"B cells promote tumor immunity against B16F10 melanoma","volume":"184","author":"Kobayashi","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2020.152821_bib0085","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ijc.21177","article-title":"Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells","volume":"117","author":"Shah","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2020.152821_bib0090","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/DCR.0b013e3181cf8ae5","article-title":"Prognostic significance of lymphovascular invasion in sporadic colorectal cancer","volume":"53","author":"Lim","year":"2010","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.prp.2020.152821_bib0095","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1200\/JCO.2009.22.4949","article-title":"Perineural invasion is an independent predictor of outcome in colorectal cancer","volume":"27","author":"Liebig","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2020.152821_bib0100","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/cmdc.200600221","article-title":"Discovery of selective irreversible inhibitors for Bruton\u2019s tyrosine kinase","volume":"2","author":"Pan","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.prp.2020.152821_bib0105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2162-3619-3-4","article-title":"Ibrutinib for B cell malignancies","volume":"3","author":"Novero","year":"2014","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.prp.2020.152821_bib0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.phrs.2016.09.011","article-title":"Ibrutinib inhibition of Bruton protein-tyrosine kinase (BTK) in the treatment of B cell neoplasms","volume":"113","author":"Roskoski","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.prp.2020.152821_bib0115","doi-asserted-by":"crossref","first-page":"E966","DOI":"10.1073\/pnas.1500712112","article-title":"Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK","volume":"112","author":"Sagiv-Barfi","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819321120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819321120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:39:42Z","timestamp":1759732782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033819321120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0344033819321120"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2020.152821","relation":{},"ISSN":["0344-0338"],"issn-type":[{"type":"print","value":"0344-0338"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of B-cell linker protein in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2020.152821","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"152821"}}